{"id":534729,"date":"2021-09-07T08:03:51","date_gmt":"2021-09-07T12:03:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/"},"modified":"2021-09-07T08:03:51","modified_gmt":"2021-09-07T12:03:51","slug":"cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/","title":{"rendered":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cortexyme to Present at H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference on September 13<sup>th<\/sup><\/b><\/p>\n<p>SOUTH SAN FRANCISCO, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Casey Lynch, chief executive officer, co-founder, and chair, and Chris Lowe, chief operating officer and chief financial officer, will participate in a fireside chat at H.C. Wainwright 23<sup>rd<\/sup> Annual Global Investment Conference taking place virtually on Monday, September 13, 2021 at 7:00 a.m. Eastern Time.\n<\/p>\n<p>\nA webcast of the event will be accessible on the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cortexyme.com%2Fnews-and-events%2Finvestor-calendar&amp;esheet=52487009&amp;newsitemid=20210907005282&amp;lan=en-US&amp;anchor=Investor+Calendar&amp;index=1&amp;md5=8a8fc006e2d41596c9be8a71d7f17f57\">Investor Calendar<\/a> page under the News &amp; Events heading of Cortexyme\u2019s investor website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.cortexyme.com%2F&amp;esheet=52487009&amp;newsitemid=20210907005282&amp;lan=en-US&amp;anchor=ir.cortexyme.com&amp;index=2&amp;md5=7621c23e54dd6f465c0860b6722ba5b0\">ir.cortexyme.com<\/a>. The webcast will be archived at that location for 90 days.\n<\/p>\n<p><b>About Cortexyme<\/b><\/p>\n<p>\nCortexyme, Inc. (Nasdaq: CRTX) is a clinical stage biopharmaceutical company pioneering upstream therapeutic approaches designed to improve the lives of patients diagnosed with Alzheimer\u2019s and other degenerative diseases. The company is advancing its disease-modifying pivotal GAIN Trial in mild to moderate Alzheimer&#8217;s disease with top-line data expected by mid-November 2021, in addition to growing a proprietary pipeline of first-in-class small molecule therapeutics for Parkinson\u2019s disease, periodontitis, and other diseases with high unmet clinical need. Cortexyme\u2019s lead program targets a specific, infectious pathogen called <i>P. gingivalis<\/i> found in the brain and other organs and tied to degeneration and inflammation in humans and animal models. The company\u2019s causation evidence for Alzheimer\u2019s disease and the mechanism of its novel therapeutic has been independently replicated and confirmed by multiple laboratories around the world, as well as published in peer-reviewed scientific journals. To learn more about Cortexyme, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.cortexyme.com&amp;esheet=52487009&amp;newsitemid=20210907005282&amp;lan=en-US&amp;anchor=www.cortexyme.com&amp;index=3&amp;md5=879df7335bf016a47510dae2ca3cce7c\">www.cortexyme.com<\/a> or follow @Cortexyme on Twitter.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210907005282\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210907005282\/en\/<\/a><\/span><\/p>\n<p><b>Corporate Contact:<br \/>\n<\/b><br \/>Stacy Roughan<br \/>\n<br \/>Vice President, Corporate Communications &amp; Investor Relations<br \/>\n<br \/>Cortexyme, Inc.<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@cortexyme.com\">ir@cortexyme.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> California United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Research Professional Services Pharmaceutical Consumer Mental Health Dental Clinical Trials Science Biotechnology Seniors Finance Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210907005282\/en\/1091862\/3\/logo_large_jpg.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Casey Lynch, chief executive officer, co-founder, and chair, and Chris Lowe, chief operating officer and chief financial officer, will participate in a fireside chat at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually on Monday, September 13, 2021 at 7:00 a.m. Eastern Time. A webcast of the event will be accessible on the Investor Calendar page under the News &amp; Events heading of Cortexyme\u2019s investor website at ir.cortexyme.com. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534729","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Casey Lynch, chief executive officer, co-founder, and chair, and Chris Lowe, chief operating officer and chief financial officer, will participate in a fireside chat at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually on Monday, September 13, 2021 at 7:00 a.m. Eastern Time. A webcast of the event will be accessible on the Investor Calendar page under the News &amp; Events heading of Cortexyme\u2019s investor website at ir.cortexyme.com. &hellip; Continue reading &quot;Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th\",\"datePublished\":\"2021-09-07T12:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/\"},\"wordCount\":361,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/\",\"name\":\"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-07T12:03:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/","og_locale":"en_US","og_type":"article","og_title":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk","og_description":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th SOUTH SAN FRANCISCO, Calif.&#8211;(BUSINESS WIRE)&#8211; Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer&#8217;s disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, announced that Casey Lynch, chief executive officer, co-founder, and chair, and Chris Lowe, chief operating officer and chief financial officer, will participate in a fireside chat at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually on Monday, September 13, 2021 at 7:00 a.m. Eastern Time. A webcast of the event will be accessible on the Investor Calendar page under the News &amp; Events heading of Cortexyme\u2019s investor website at ir.cortexyme.com. &hellip; Continue reading \"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:03:51+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th","datePublished":"2021-09-07T12:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/"},"wordCount":361,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/","name":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-07T12:03:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210907005282r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cortexyme-to-present-at-h-c-wainwright-23rd-annual-global-investment-conference-on-september-13th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cortexyme to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534729"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534729\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}